Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03463031
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ALY | N(6)-ACETYLLYSINE | A,B | 2B4D | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD9 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVR | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVS | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVQ | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OT7 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B5G | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2GIV | 0.71 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNY | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 1JSP | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,I,L | 2V5W | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,D | 3D4B | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OQ6 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R0Y | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 3CZ7 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 1JM4 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H4H | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2J6V | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R10 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1YC5 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OX0 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2G | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,D | 2H4F | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2OU2 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1S5P | 0.71 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNW | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 3D35 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD2 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2ZFN | 0.71 | |
ALY | N(6)-ACETYLLYSINE | C,D | 2C1J | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQG | 0.71 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNX | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1MA3 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2H | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2I2Z | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD7 | 0.71 | |
ALY | N(6)-ACETYLLYSINE | P | 1E6I | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZC | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D,I,J, K,L | 3EWF | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2D | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1Q1A | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZD | 0.71 | |
ALY | N(6)-ACETYLLYSINE | Q,R | 2E3K | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A | 2OZU | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQF | 0.71 | |
ALY | N(6)-ACETYLLYSINE | A,B,C | 2R0V | 0.71 | |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.71 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.7 | |
0AG | N-(ethoxycarbonyl)-L-leucine | I,J | 1PSA | 0.73 | |
BUJ | (3R)-3-(hexadecanoylamino)-4-(trimethylammonio)butanoate | A,B | 2RCU | 0.71 | |
AHE | 2-AMINO-4-[1-CARBOXYMETHYL-CARBAMOYL)- 2-HYDROXYMETHYLSULFANYL-ETHYLCARBAMOYL]- BUTYRIC ACID | A | 3BHM | 0.71 | |
AHE | 2-AMINO-4-[1-CARBOXYMETHYL-CARBAMOYL)- 2-HYDROXYMETHYLSULFANYL-ETHYLCARBAMOYL]- BUTYRIC ACID | A,B | 1MC5 | 0.71 | |
5FP | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.72 | |
AN0 | N-ACETYL-L-NORVALINE | C,D,E,X,Y,Z | 2G7M | 0.71 | |
AN0 | N-ACETYL-L-NORVALINE | A | 1ZQ8 | 0.71 | |
BCV | D-(L-A-AMINOADIPOYL)-L-CYSTEINYL- D-CYCLOPROPYLGLYCINE | A | 2IVJ | 0.71 | |
ABX | 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]- 4-(METHOXYCARBONYL)PROLINE | A | 1XOE | 0.72 | |
5FE | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID METHYL ESTER | A,B | 1XE5 | 0.71 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.74 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.74 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.74 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.74 | |
AOR | N~2~-ACETYL-L-ORNITHINE | A | 1ZQ6 | 0.72 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.75 | |
CIB | 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1- (1-FORMYL-PENTYLCARBAMOYL)-3-METHYL- BUTYL]-AMIDE | H,I,J,K,L,M,N | 1J2Q | 0.73 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.75 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.75 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.75 | |
AIO | [(2R)-1-(L-ALANYL-L-ISOLEUCYL)PYRROLIDIN- 2-YL]BORONIC ACID | A | 2EEP | 0.71 | |
AIO | [(2R)-1-(L-ALANYL-L-ISOLEUCYL)PYRROLIDIN- 2-YL]BORONIC ACID | A | 2Z3Z | 0.71 | |
52A | (2R,4R)-4-aminopyrrolidine-2,4- dicarboxylic acid | A,B | 2E4Y | 0.73 | |
CLH | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.71 | |
3GC | GAMMA-GLUTAMYLCYSTEINE | A,B | 2BU3 | 0.71 | |
3GC | GAMMA-GLUTAMYLCYSTEINE | A,B | 1M0W | 0.71 |